1
Virgil A Place, Leland F Wilson, Paul C Doherty Jr, Mark S Hanamoto, Alfred P Spivack, Neil Gesundheit, Sean R Bennett: VIVUS Incorporated, Dianne E Bozicevic & Reed Reed, March 2, 1999: US05877216 (145 worldwide citation)

Methods and formulations for treating female sexual dysfunction are provided. A pharmaceutical composition formulated so as to contain a selected vasodilating agent is administered to the vagina or vulvar area of the individual undergoing treatment. Suitable vasodilating agents include naturally occ ...


2
Virgil A Place, Leland F Wilson, Paul C Doherty Jr, Mark S Hanamoto, Alfred P Spivack, Neil Gesundheit, Sean R Bennett: Asivi, Dianne E Reed, Reed & Associates, September 25, 2001: US06294550 (109 worldwide citation)

Methods and formulations for treating female sexual dysfunction are provided. A pharmaceutical composition formulated so as to contain a selected vasoactive agent is administered to the vagina, vulvar area or urethra of the individual undergoing treatment. Suitable vasoactive agents are vasodilators ...


3
Virgil A Place, Leland F Wilson, Paul C Doherty Jr, Mark S Hanamoto, Alfred P Spivack, Neil Gesundheit, Sean R Bennett: ASIVI, Dianne E Reed, Reed & Associates, October 23, 2001: US06306841 (107 worldwide citation)

Methods and formulations for treating female sexual dysfunction are provided. A pharmaceutical composition formulated so as to contain a selected vasoactive agent is administered to the vagina, vulvar area or urethra of the individual undergoing treatment. Suitable vasoactive agents are vasodilators ...


4
Virgil A Place, Leland F Wilson, Paul C Doherty Jr, Mark S Hanamoto, Alfred P Spivack, Neil Gesundheit, Sean R Bennett: Vivus, Diane E Reed, Reed & Associates, October 22, 2002: US06469016 (60 worldwide citation)

Methods and formulations for treating female sexual dysfunction are provided. A pharmaceutical composition formulated so as to contain a selected vasoactive agent is administered to the vagina, vulvar area or urethra of the individual undergoing treatment. Suitable vasoactive agents are vasodilators ...


5
Virgil A Place, Leland F Wilson, Paul C Doherty Jr, Mark S Hanamoto, Alfred P Spivack, Neil Gesundheit, Sean R Bennett: Method for minimizing excess collagen deposition. Vivus, Dianne E Reed, Reed & Associates, October 29, 2002: US06472434 (46 worldwide citation)

Methods and formulations for minimizing excess collagen are provided. A pharmaceutical composition formulated so as to contain a selected vasoactive agent is administered to the vagina, vulvar area or urethra of the individual undergoing treatment. Suitable vasoactive agents are vasodilators, includ ...


6
Virgil A Place, Leland F Wilson, Paul C Doherty Jr, Mark S Hanamoto, Alfred P Spivack, Neil Gesundheit, Sean R Bennett: Vivus, Dianne E Reed, Reed & Eberle, July 15, 2003: US06593313 (43 worldwide citation)

Methods and formulations for treating female sexual dysfunction are provided. A pharmaceutical composition formulated so as to contain a selected vasoactive agent is administered to the vagina, vulvar area or urethra of the individual undergoing treatment. Suitable vasoactive agents are vasodilators ...


7
Leland F Wilson, Paul C Doherty Jr, Virgil A Place, William L Smith, Ibrahim AbouBakr Abdel Hamid Abdou Ali: Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation. Vivus, Dianne E Reed, Reed & Associates, June 11, 2002: US06403597 (41 worldwide citation)

A method is provided for treatment of premature ejaculation by administration of a phosphodiesterase inhibitor, e.g., an inhibitor of a Type III, Type IV, or Type V phosphodiesterase. In a preferred embodiment, administration is on as “as needed” basis, i.e., the drug is administered immediately or ...


8
Leland F Wilson, Virgil A Place: Vivus, Mintz Levin Cohn Ferris Glovsky and Popeo P C, Carol Schneider, Isaac M Rutenberg, June 5, 2007: US07226910 (36 worldwide citation)

Methods for treating female sexual dysfunction are provided. A pharmaceutical composition containing a vasoactive agent selected from vasoactive intestinal potypeptide (VIP) and VIP agonists is administered to the vagina and/or vulvar region of the individual undergoing treatment. The formulations a ...


9
Peter Tam, Neil Gesundheit, Leland F Wilson: On demand administration of clomipramine and salts thereof to treat premature ejaculation. Vivus, Dianne E Reed, Reed & Associates, December 17, 2002: US06495154 (27 worldwide citation)

A method is provided for delaying the onset of ejaculation in an individual. The method involves systemic and on demand administration to an individual of a pharmaceutical formulation containing an amount of an active agent selected from the group consisting of clomipramine and pharmacologically acc ...


10
Peter Tam, Neil Gesundheit, Leland F Wilson: As-needed administration of tricyclic and other non-SRI antidepressant drugs to treat premature ejaculation. Vivus, Dianne E Reed, Reed Intellectural Property Law Group, September 20, 2005: US06946141 (7 worldwide citation)

A method is provided for treatment of premature ejaculation by administration of an antidepressant drug selected from tricyclic antidepressants, tetracyclic antidepressants, MAO inhibitors, azaspirone antidepressants, and atypical non-SRI antidepressants. In a preferred embodiment, administration is ...